Ecotoxicity of ketoprofen, diclofenac, atenolol and their photolysis byproducts in zebrafish (Danio rerio)

Science of the Total Environment

Volumn 505, Issue , 2015, Pages 282-289

  Diniz, M S ^a   Salgado, R ^a,b   Pereira, V J ^c,d   Carvalho, G ^a,c   Oehmen, A ^a   Reis, M A M ^a   Noronha, J P ^a  

^a DEPARTAMENTO DE QUÍMICA   (Portugal)

^b INSTITUTO POLITÉCNICO DE SETÚBAL   (Portugal)

^c INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^d INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

By products; Oxidative stress; Pharmaceuticals; Photolysis; Toxicity; Zebrafish

Indexed keywords

DRUG PRODUCTS; OXIDATIVE STRESS; PHOTOLYSIS; TOXICITY;

ATENOLOL; DANIO RERIO; DICLOFENAC; ECOTOXICITY; KETOPROFEN; ZEBRAFISH;

BYPRODUCTS;

ATENOLOL; CATALASE; DICLOFENAC; GLUTATHIONE TRANSFERASE; KETOPROFEN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; WASTE WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); CYPRINID; DRUG; ECOTOXICOLOGY; ENZYME; LIPID; OXIDATION; PHOTOLYSIS; TOXICITY;

ACUTE TOXICITY; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECOTOXICITY; ENVIRONMENTAL IMPACT; ENVIRONMENTAL MONITORING; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; LIMIT OF DETECTION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PHOTODEGRADATION; PHOTOLYSIS; ULTRAVIOLET IRRADIATION; ZEBRA FISH; ANIMAL; CHEMISTRY; METABOLISM; TOXICITY; WASTE WATER; WATER POLLUTANT;

DANIO RERIO;

ANIMALS; ATENOLOL; CATALASE; DICLOFENAC; FEMALE; GLUTATHIONE TRANSFERASE; KETOPROFEN; MALE; OXIDATIVE STRESS; PHOTOLYSIS; SUPEROXIDE DISMUTASE; WASTE WATER; WATER POLLUTANTS, CHEMICAL; ZEBRAFISH;

EID: 84908147820     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.09.103     Document Type: Article

References (64)

1. Aebi H. Catalase invitro. Methods Enzymol 1984, 105:121-126.
2. Behera S.K., Kim H.W., Oh J.-E., Park H.-S. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci Total Environ 2011, 409:4351-4360.
3. Belyaeva O.V., Lee S.-A., Kolupaev O.V., Kedishvili N.Y. Identification and characterization of retinoid-active short-chain dehydrogenases/reductases in Drosophila melanogaster. Biochim Biophys Acta 2009, 1790:1266-1273.
4. Boxall A.B., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., Hickmann S., et al. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ Health Perspect 2012, 120:1221-1229.
5. Bradford M.M. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
6. Brandao F.P., Rodrigues S., Castro B.B., Goncalves F., Antunes S.C., Nunes B. Short-term effects of neuroactive pharmaceutical drugs on a fish species: biochemical and behavioural effects. Aquat Toxicol 2013, 144:218-229.
7. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 1978, 52:302-310.
8. 2 suspensions. Appl Catal B Environ 2006, 67:197-205.
9. Canonica S., Meunier L., Von Gunten U. Phototransformation of selected pharmaceuticals during UV treatment of drinking water. Water Res 2008, 42:121-128.
10. Cardoso O., Porcher J.C., Sanchez W. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge. Chemosphere 2014, 115:20-30.
11. Carlsson C., Johansson A.-K., Alvan G., Bergman K., Kuhler T. Are pharmaceuticals potent environmental pollutants? Part I: Environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ 2006, 364:67-87.
12. Celik I., Tuluce Y., Turker M. Antioxidant and immune potential marker enzymes assessment in the various tissues of rats exposed to indoleacetic acid and kinetin: a drinking water study. Pestic Biochem Physiol 2006, 86:180-185.
13. Choi J., Lee H., Choi Y., Kim S., Lee S., Lee S., et al. Heterogeneous photocatalytic treatment of pharmaceutical micropollutants: effects of wastewater effluent matrix and catalyst modifications. Appl Catal B Environ 2014, 147:8-16.
14. Christen V., Hickmann S., Rechenberg B., Fent K. Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action. Aquat Toxicol 2010, 96:167-181.
15. Cleuvers M. Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 2005, 59:199-205.
16. Coelho A.D., Sans C., Aguera A., Gomez M.J., Esplugas S., Dezotti M. Effects of ozone pre-treatment on diclofenac: intermediates, biodegradability and toxicity assessment. Sci Total Environ 2009, 407:3572-3578.
17. Cuklev F., Fick J., Cvijovic M., Kristiansson E., Forlin L., Larsson D.G.J. Does ketoprofen or diclofenac pose the lowest risk to fish?. J Hazard Mater 2012, 229:100-106.
18. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
19. Di Giulio R.T., Meyer J.N. Reactive oxygen species and oxidative stress. The toxicology of fishes 2008, 273-324. CRC Press. R.T. Di Giulio, D.E. Hinton (Eds.).
20. Du B., Price A.E., Scott W.C., Kristofco L.A., Ramirez A.J., Chambliss C.K., et al. Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system effluents receiving common wastewater influent. Sci Total Environ 2014, 466-467:976-984.
21. Fang T.-H., Nan F.-H., Chin T.-S., Feng H.-M. The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters. Mar Pollut Bull 2012, 64:1435-1444.
22. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
23. Fernández M., Fernández M., Laca A., Laca A., Díaz M. Seasonal occurrence and removal of pharmaceutical products in municipal wastewaters. J Environ Chem Eng 2014, 2:495-502.
24. Ferrari B., Paxeus N., Lo Giudice R., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 2003, 55:359-370.
25. Garcia S.N., Clubbs R.L., Stanley J.K., Scheffe B., Yelderman J.C., Brooks B.W. Comparative analysis of effluent water quality from a municipal treatment plant and two on-site wastewater treatment systems. Chemosphere 2013, 92:38-44.
26. Gong X., Shang F., Obin M., Palmer H., Scrofano M.M., Jahngen-Hodge J., et al. Antioxidant enzyme activities in lens, liver and kidney of calorie restricted Emory mice. Mech Ageing Dev 1997, 99:181-192.
27. Gonzalez-Rey M., Bebianno M.J. Effects of non-steroidal anti-inflammatory drug (NSAID) diclofenac exposure in mussel Mytilus galloprovincialis. Aquat Toxicol 2014, 148:221-230.
28. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases-first enzymatic step in mercapturic acid formation. J Biol Chem 1974, 249:7130-7139.
29. Hallare A.V., Kohler H.R., Triebskorn R. Development toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvents, DMSO. Chemosphere 2004, 56:659-666.
30. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 2002, 131:5-17.
31. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86:6-19.
32. Himmelfarb J., Hakim R.M. Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003, 12:593-598.
33. Hoeger B., Kollner B., Dietrich D.R., Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat Toxicol 2005, 75:53-64.
34. Jelic A., Gros M., Petrovic M., Ginebreda A., Barcelo D. Occurrence and elimination of pharmaceuticals during conventional wastewater treatment. Emerging and priority pollutants in rivers 2012, 1-23. Springer, Berlin Heidelberg. H. Guasch, A. Ginebreda, A. Geiszinger (Eds.).
35. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 2009, 43:363-380.
36. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
37. Kuemmerer K. The presence of pharmaceuticals in the environment due to human use-present knowledge and future challenges. J Environ Manage 2009, 90:2354-2366.
38. Kuemmerer K. Pharmaceuticals in the environment. Annual Review of Environment and Resources 2010, vol. 35:57-75. A. Gadgil, D.M. Liverman (Eds.).
39. Letzel M., Metzner G., Letzel T. Exposure assessment of the pharmaceutical diclofenac based on long-term measurements of the aquatic input. Environ Int 2009, 35:363-368.
40. Livingstone D.R. Contaminant-stimulated reactive oxygen species production and oxidative damage in aquatic organisms. Mar Pollut Bull 2001, 42:656-666.
41. Livingstone D.R. Oxidative stress in aquatic organisms in relation to pollution and aquaculture. Rev Med Vet Toulouse 2003, 154:427-430.
42. Matamoros V., Arias C., Brix H., Bayona J.M. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical flow constructed wetland and a sand filter. Environ Sci Technol 2007, 41:8171-8177.
43. Moreno-González R., Rodríguez-Mozaz S., Gros M., Pérez-Cánovas E., Barceló D., León V.M. Input of pharmaceuticals through coastal surface watercourses into a Mediterranean lagoon (Mar Menor, SE Spain): sources and seasonal variations. Sci Total Environ 2014, 490:59-72.
44. Oppenländer T. Photochemical purification of water and Air advanced oxidation processes: principles, reaction mechanisms, reactor concepts. Chem Int 2003, 25:368.
45. Oruc E.O., Uner N. Marker enzyme assesment in the liver of Cyprinus carpio (L.) exposed to 2,4-D and azinphosmethyl. J Biochem Mol Toxicol 2002, 16:182-188.
46. Parolini M., Quinn B., Binelli A., Provini A. Cytotoxicity assessment of four pharmaceutical compounds on the zebra mussel (Dreissena polymorpha) haemocytes, gill and digestive gland primary cell cultures. Chemosphere 2011, 84:91-100.
47. Praskova E., Voslarova E., Siroka Z., Plhalova L., Macova S., Marsalek P., et al. Assessment of diclofenac LC50 reference values in juvenile and embryonic stages of the zebrafish (Danio rerio). Pol J Vet Sci 2011, 14:545-549.
48. Praskova E., Voslarova E., Siroka Z., Macova S., Plhalova L., Bedanova I., et al. Comparison of acute toxicity of ketoprofen to juvenile and embryonic stages of Danio rerio. Neuro Endocrinol Lett 2011, 32(Suppl. 1):117-120.
49. Prášková E., Štěpánová S., Chromcová L., Plhalová L., Voslářová E., Pištěková V., et al. The effects of subchronic exposure to ketoprofen on early developmental stages of common carp. Acta Vet Brno 2013, 82:343-347.
50. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43:831-841.
51. 2 treatment for the oxidation of pharmaceuticals in wastewater. Water Res 2010, 44:1440-1448.
52. Salgado R., Marques R., Noronha J.P., Carvalho G., Oehmen A., Reis M.A.M. Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. Environ Sci Pollut Res 2012, 19:1818-1827.
53. Salgado R., Pereira V.J., Carvalho G., Soeiro R., Gaffney V., Almeida C., et al. Photodegradation kinetics and transformation products of ketoprofen, diclofenac and atenolol in pure water and treated wastewater. J Hazard Mater 2013, 244:516-527.
54. Sanderson H., Johnson D.J., Wilson C.J., Brain R.A., Solomon K.R. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 2003, 144:383-395.
55. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac Part 1: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 2004, 68:141-150.
56. Selderslaghs I.W.T., Van Rompay A.R., De Coen W., Witters H.E. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol 2009, 28:308-320.
57. Sevcikova L., Pechova A., Pavlata L., Antos D., Mala E., Palenik T., et al. The effect of various forms of selenium supplied to pregnant goats on the levels of selenium in the body of their kids at the time of weaning. Biol Trace Elem Res 2011, 143:882-892.
58. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide-dismutase. Clin Chem 1988, 34:497-500.
59. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978, 86:271-278.
60. van den Brandhof E.-J., Montforts M. Fish embryo toxicity of carbamazepine, diclofenac and metoprolol. Ecotoxicol Environ Saf 2010, 73:1862-1866.
61. van der Oost R., Beyer J., Vermeulen N.P.E. Fish bioaccumulation and biomarkers in environmental risk assessment: a review. Environ Toxicol Pharmacol 2003, 13:57-149.
62. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 2012, 429:123-155.
63. 2 and ozone. Water Res 2004, 38:414-422.
64. Winter M.J., Lillicrap A.D., Caunter J.E., Schaffner C., Alder A.C., Ramil M., et al. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat Toxicol 2008, 86:361-369.